Peanuts is not consistent with Jon's aspiration of maximising shareholder value.
Nor does it reflect a realistic valuation which Karst have indicated is not where we are at presently.
Would Karst accept an early TO with a reduced valuation? I don't know but there are other parties that will contribute to the ultimate decision. From a negotiating point of view though, there is now considerable leverage following recent phase 3 success.
We will no doubt get to see the conviction behind Jon's statement that he will have SH interests at the forefront in the event of an offer.
I for one believe he will.
- Forums
- ASX - By Stock
- NEU
- Share Price
NEU
neuren pharmaceuticals limited
Add to My Watchlist
4.06%
!
$17.70

Share Price, page-230
-
- There are more pages in this discussion • 2,532 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$17.70 |
Change
0.690(4.06%) |
Mkt cap ! $2.222B |
Open | High | Low | Value | Volume |
$17.48 | $18.44 | $17.40 | $12.39M | 693.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 91 | $17.69 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$17.70 | 15 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 32 | 17.710 |
1 | 55 | 17.700 |
6 | 306 | 17.690 |
5 | 320 | 17.680 |
5 | 896 | 17.670 |
Price($) | Vol. | No. |
---|---|---|
17.730 | 81 | 2 |
17.740 | 238 | 3 |
17.750 | 262 | 2 |
17.760 | 809 | 3 |
17.770 | 383 | 3 |
Last trade - 15.07pm 07/08/2025 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |